Acrivon Therapeutics Statistics

Total Valuation

ACRV has a market cap or net worth of $41.08 million. The enterprise value is -$93.08 million.

Market Cap	41.08M
Enterprise Value	-93.08M

Important Dates

The last earnings date was Wednesday, August 13, 2025, after market close.

Earnings Date	Aug 13, 2025
Ex-Dividend Date	n/a

Share Statistics

ACRV has 31.36 million shares outstanding. The number of shares has increased by 48.59% in one year.

Current Share Class	31.36M
Shares Outstanding	31.36M
Shares Change (YoY)	+48.59%
Shares Change (QoQ)	+0.29%
Owned by Insiders (%)	7.42%
Owned by Institutions (%)	25.06%
Float	16.67M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	0.29
P/TBV Ratio	0.29
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 10.31, with a Debt / Equity ratio of 0.02.

Current Ratio	10.31
Quick Ratio	10.23
Debt / Equity	0.02
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -47.87% and return on invested capital (ROIC) is -32.19%.

Return on Equity (ROE)	-47.87%
Return on Assets (ROA)	-30.32%
Return on Invested Capital (ROIC)	-32.19%
Return on Capital Employed (ROCE)	-65.04%
Revenue Per Employee	n/a
Profits Per Employee	-$1.10M
Employee Count	78
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -82.74% in the last 52 weeks. The beta is 1.67, so ACRV's price volatility has been higher than the market average.

Beta (5Y)	1.67
52-Week Price Change	-82.74%
50-Day Moving Average	1.29
200-Day Moving Average	3.94
Relative Strength Index (RSI)	50.63
Average Volume (20 Days)	257,089

Short Selling Information

The latest short interest is 696,368, so 2.22% of the outstanding shares have been sold short.

Short Interest	696,368
Short Previous Month	598,604
Short % of Shares Out	2.22%
Short % of Float	4.18%
Short Ratio (days to cover)	2.29

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-94.41M
Pretax Income	-64.12M
Net Income	-85.96M
EBITDA	-93.21M
EBIT	-94.41M
Earnings Per Share (EPS)	-$2.25

Full Income Statement

Balance Sheet

The company has $137.42 million in cash and $3.26 million in debt, giving a net cash position of $134.16 million or $4.28 per share.

Cash & Cash Equivalents	137.42M
Total Debt	3.26M
Net Cash	134.16M
Net Cash Per Share	$4.28
Equity (Book Value)	143.04M
Book Value Per Share	4.55
Working Capital	124.98M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$70.83 million and capital expenditures -$2.37 million, giving a free cash flow of -$73.20 million.

Operating Cash Flow	-70.83M
Capital Expenditures	-2.37M
Free Cash Flow	-73.20M
FCF Per Share	-$2.33

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

ACRV does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-48.59%
Shareholder Yield	-48.59%
Earnings Yield	-209.27%
FCF Yield	-178.20%

Analyst Forecast

The average price target for ACRV is $17.60, which is 1,243.51% higher than the current price. The consensus rating is "Buy".

Price Target	$17.60
Price Target Difference	1,243.51%
Analyst Consensus	Buy
Analyst Count	7
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	-3.63%

Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	1